High prevalence of resistant bacterial infections in patients with tracheostomy due to neuromuscular disease (NMD) Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Modification of empirical antibiotic therapy in community acquired pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
The impact of mixed etiology in community acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
Comparative evaluation of timing of antibiotic intravenous-to-oral switch in pneumonia Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Etiological features of low respiratory tract infections in the department of pulmonology. Update 2013 Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Extended-spectrum-beta-lactamase producing multidrug resistant nosocomial bacterial isolates causing lower respiratory tract infection in Tertiary Care Hospital, Nepal Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Frequency of multidrug resistant pathogens in healthcare associated pneumonia Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Multidrug resistant acinetobacter baumanii pneumonia: Mortality analysis and comparison of intravenous versus aerosolized therapy Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Monitoring of antimicrobial resistance respiratory strains of streptococcus pneumoniae Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Modern etiology of severe community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014
The prevalence of cardiac diseases in patients with community-acquired pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Effect of N-acetylcysteine on the activity of antibiotics against relevant respiratory pathogens Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016
The efficacy of adjuvant use low molecular weight heparins in patients with community-acquired pneumonia Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014
Drug-resistant pathogens prediction scores in CAP, HCAP and immunocompromised Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014
Community acquired pneumonia in patients with ambulatory treatment. Etiology and evolution Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Cavitary bacterial lung infections – Predictive factors and outcomes Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014
Relationship between bacterial sensivity pattern and hospital antibiotic consumption,in patients with community acquired pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Primary ciliary dyskinesia: Respiratory tract infections and impact of pseudomonas aeruginosa Source: International Congress 2014 – Respiratory physiology and sleep disordered breathing in children Year: 2014
Viral infections of the lower respiratory tract and the presence of pneumonia in preschool children Source: International Congress 2014 – Virus-triggered lower respiratory disease in children Year: 2014